Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Indonesia
100%
COVID-19
68%
Tuberculosis
55%
Mycobacterium Tuberculosis (M. tb)
49%
Helicobacter Pylori (H. pylori)
45%
Podocyte Injury
45%
Fecal Calprotectin
42%
Hepatic Hydrothorax
42%
Colorectal Cancer Patients
42%
Predictive Score
42%
Referral Hospital
42%
Sputum Culture
39%
Urea Breath Test
36%
Xpert
29%
Glomerulosclerosis
27%
Staphylococcus Aureus
27%
14C-urea Breath Test
26%
Podocyte
25%
Eye Drops
25%
Intensive Care Unit
25%
Pleural Effusion
24%
Gastric Biopsy
24%
Etiology
24%
Gastritis
24%
Indonesian
23%
Sepsis
22%
Recombinant
22%
Chronic Kidney Disease
22%
Baumannii
22%
Acid-fast Bacilli
21%
Obstructive Jaundice
21%
Interleukin-1β
21%
Fc-fusion Protein
21%
SARS-CoV-2 Variants of Concern
21%
Infection Kinetics
21%
In Vitro Approach
21%
Epigallocatechin Gallate
21%
Osteitis Fibrosa Cystica
21%
Importin
21%
Brown Tumor
21%
Nuclear Localization
21%
Pseudomonas Aeruginosa Keratitis
21%
Dendrin
21%
Culture Filtrate
21%
H37Rv
21%
Percutaneous Transhepatic Biliary Drainage
21%
Palliation
21%
Injury Biomarkers
21%
Gastroduodenal Perforation
21%
Refractory Esophageal Strictures
21%
Matrix metalloproteinase-9 (MMP-9)
21%
Inflammatory Biomarkers
21%
Urease
21%
Xpert MTB
21%
Toluidine Blue
21%
Time to Detection
21%
Gasoline
21%
Potential Therapeutics
21%
Duodenal Ulcer
21%
Eastern Indonesia
21%
C-reactive Protein
21%
Sputum Microscopy
21%
Calu-3 Cells
21%
Fine-needle Aspiration Biopsy
21%
Syncytium Formation
21%
Plant-produced
21%
Tuberculosis Diagnosis
21%
Angiotensin-converting Enzyme 2 (ACE2)
21%
Liver Cirrhosis
21%
Acute Gastritis
21%
Chronic Gastritis
21%
Plant Development
21%
Natural Killer Cells
21%
Cholangiocarcinoma
21%
Diagnostic Value
21%
Intestinal Injury
21%
Pathogenicity
21%
Atrophic Gastritis
21%
Colitis
21%
Clinical Outcomes
21%
MGIT 960
21%
Immunohistochemistry
21%
Complementary Therapies
21%
Tuberculosis Transmission
21%
Tuberculosis Prevention
21%
Mycobacterium Tuberculosis Detection
21%
Liver Abnormality
21%
Endothelin Signalling
21%
Xpert Carba-R
21%
Diabetic Kidney Disease
21%
High Burden
21%
Intensive Care Patients
21%
Diabetic Nephropathy
21%
Carbapenem Resistance
21%
Postoperative Endophthalmitis
21%
Bacteriophage
21%
Ward Patients
21%
Pharmacological Strategies
21%
Gut Microbiota Profiles
21%
Glomerular Injury
21%
Medicine and Dentistry
Systematic Review
63%
Helicobacter Pylori
63%
Patient Referral
63%
Podocyte
59%
Mycobacterium Tuberculosis
49%
Hydrothorax
42%
COVID-19
42%
Intensive Care Unit
42%
Urea Breath Test
37%
Diseases
37%
Sputum Culture
36%
Rifampicin
35%
Liver Cirrhosis
32%
Odds Ratio
30%
Retrospective Study
30%
Cross Sectional Study
28%
Prevalence
27%
Randomized Controlled Trial
26%
Pseudomonas aeruginosa
26%
Neoplasm
25%
Carbon 14
25%
Glomerulosclerosis
25%
Chronic Kidney Disease
24%
Antibiotic Resistance
24%
Pleura Effusion
24%
Lung Tuberculosis
24%
Cohort Analysis
24%
In Vitro
24%
Gastritis
24%
Stomach Biopsy
24%
Acinetobacter Baumannii
23%
Congestive Heart Failure
23%
Sepsis
22%
Infection
21%
Meta-Analysis
21%
Carbapenem
21%
Diagnosis
21%
Obstructive Jaundice
21%
Esophageal Stricture
21%
Acid Fast Bacterium
21%
Sputum Cytodiagnosis
21%
Karyopherin
21%
Faecal Calprotectin
21%
Intestine Injury
21%
Biliary Tract Drainage
21%
Epigallocatechin Gallate
21%
Patient with Complication
21%
Jejunum Ulcer
21%
Urease
21%
Symptomatic Treatment
21%
Complementary Therapy
21%
Fine-Needle Aspiration
21%
Cytotechnology
21%
Immunohistochemistry
21%
Keratitis
21%
Biological Marker
21%
Histopathology
21%
Interleukin 1
21%
Cholangiocarcinoma
21%
Gelatinase B
21%
Tolonium Chloride
21%
Ingestion
21%
Colorectal Carcinoma
21%
Diabetic Nephropathy
21%
Endothelin
21%
Hyperbilirubinemia
21%
Nonalcoholic Fatty Liver
21%
Diabetes Mellitus
21%
Tuberculosis Diagnosis
21%
Bloodstream Infection
21%
Transjugular Intrahepatic Portosystemic Shunt
21%
Inflammatory Bowel Disease
21%
Dysbiosis
21%
Gut Microbiome
21%
Macrophage Polarization
21%
Gamma Chemokine
21%
Drug Resistant Tuberculosis
21%
Angiotensin
21%
Physical Activity
21%
Obesity Management
21%
Network Meta-Analysis
21%
e-Health
21%
Remote Patient Monitoring
21%
Autoimmune Liver Disease
21%
Ascites
19%
Acute Respiratory Distress Syndrome
19%
Albright's Hereditary Osteodystrophy
18%
Liver Injury
17%
Chronic Gastritis
16%
Atrophic Gastritis
16%
Laparoscopic Surgery
15%
Blood Culture
15%
Moxifloxacin
15%
Pleural Cavity
14%
Diabetes
14%
Public Health
12%
Metabolic Dysfunction-Associated Steatotic Liver Disease
12%
Thorax Pain
11%
Thoracentesis
11%
Sputum
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
71%
Infection
45%
Coronavirinae
44%
Carbapenem
42%
SARS Coronavirus
42%
Calgranulin
42%
Biological Marker
42%
Mycobacterium Tuberculosis
42%
Retrospective Study
27%
Pseudomonas aeruginosa
26%
Prevalence
24%
Neoplasm
23%
Antimicrobial Resistance
23%
Acinetobacter Baumannii
23%
Glomerulosclerosis
23%
Sepsis
22%
Colitis
21%
Angiotensin Converting Enzyme 2
21%
Keratitis
21%
Jejunum Ulcer
21%
Urease
21%
C Reactive Protein
21%
Gastritis
21%
Epigallocatechin Gallate
21%
Interleukin 1
21%
Karyopherin
21%
Gelatinase B
21%
Pathogenicity
21%
Chronic Kidney Failure
21%
Intestine Injury
21%
Colorectal Carcinoma
21%
Chimeric Protein
21%
Diabetic Nephropathy
21%
Endothelin
21%
Helicobacter Pylori
21%
Peptic Ulcer
21%
Methicillin-Resistant Staphylococcus Aureus
21%
Bloodstream Infection
21%
Lung Tuberculosis
21%
Cohort Study
21%
Autoimmune Liver Disease
21%
Adult Respiratory Distress Syndrome
19%
Albright Syndrome
18%
Liver Injury
17%
Urea Breath Test
16%
Chronic Gastritis
16%
Atrophic Gastritis
16%
Moxifloxacin
15%
Cross-Sectional Study
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Cytokine
10%
Delta Variant
10%
Communicable Disease
10%
Mycobacteria
10%
Infectious Agent
10%
Mitochondrion Antibody
10%
Calcium Supplement
10%
Smooth Muscle Antibody
10%
Guanylate Kinase
9%
Stomach Acid
8%
Carbapenem Resistance
8%
Endothelin Receptor Antagonist
8%
Multidrug Resistance
8%
Inflammation
8%
Anti-Inflammatory Drug
7%
Procalcitonin
7%
Adriamycin-Induced Nephropathy
7%
Kidney Disease
7%
Hypoalbuminemia
7%
Human Immunodeficiency Virus Infection
7%
Cation
7%
Polyene
7%
Mortality Rate
6%
Receptor
5%
Side Effect
5%
Stomach Perforation
5%
Chemotherapy
5%
Fibroblast Growth Factor 2
5%
Tumor Necrosis Factor
5%
Growth Factor
5%
Pandemic
5%
Rattus norvegicus
5%
Disease Severity
5%
Chemokine
5%
Vasculotropin A
5%
Enterobacteriaceae
5%
Staphylococcus Aureus
5%
Interleukin 6
5%
Etiology
5%
Tonsillitis
5%
Agar
5%
Antibiotics
5%